Raymond James & Associates Increases Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Raymond James & Associates grew its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 40.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,730 shares of the company’s stock after buying an additional 3,654 shares during the quarter. Raymond James & Associates owned 0.10% of U.S. Physical Therapy worth $1,545,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in USPH. BlackRock Inc. raised its position in U.S. Physical Therapy by 1.1% in the 1st quarter. BlackRock Inc. now owns 2,076,064 shares of the company’s stock worth $206,466,000 after purchasing an additional 22,653 shares during the period. Vanguard Group Inc. raised its position in U.S. Physical Therapy by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 927,480 shares of the company’s stock worth $92,238,000 after purchasing an additional 10,015 shares during the period. T. Rowe Price Investment Management Inc. raised its position in U.S. Physical Therapy by 0.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 915,831 shares of the company’s stock worth $74,210,000 after purchasing an additional 3,618 shares during the period. Copeland Capital Management LLC raised its position in U.S. Physical Therapy by 4.1% in the 2nd quarter. Copeland Capital Management LLC now owns 721,458 shares of the company’s stock worth $87,578,000 after purchasing an additional 28,178 shares during the period. Finally, Morgan Stanley raised its position in U.S. Physical Therapy by 438.2% in the 4th quarter. Morgan Stanley now owns 702,170 shares of the company’s stock worth $56,897,000 after purchasing an additional 571,710 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on USPH shares. JPMorgan Chase & Co. started coverage on shares of U.S. Physical Therapy in a research report on Friday, September 22nd. They set an “overweight” rating and a $108.00 target price on the stock. Barrington Research raised their target price on shares of U.S. Physical Therapy from $116.00 to $124.00 and gave the stock an “outperform” rating in a research report on Monday, August 14th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, October 18th. TheStreet lowered shares of U.S. Physical Therapy from a “b-” rating to a “c+” rating in a research report on Wednesday, October 4th. Finally, CJS Securities raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating in a research report on Tuesday, September 19th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $123.33.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $109.95, for a total value of $109,950.00. Following the completion of the sale, the director now directly owns 9,280 shares in the company, valued at $1,020,336. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 4,114 shares of the firm’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $109.99, for a total value of $452,498.86. Following the completion of the transaction, the chief operating officer now owns 7,577 shares of the company’s stock, valued at $833,394.23. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Edward L. Kuntz sold 1,000 shares of the firm’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $109.95, for a total transaction of $109,950.00. Following the completion of the transaction, the director now directly owns 9,280 shares of the company’s stock, valued at approximately $1,020,336. The disclosure for this sale can be found here. Insiders sold a total of 6,114 shares of company stock worth $670,049 over the last three months. Corporate insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Price Performance

NYSE USPH opened at $82.98 on Thursday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.82 and a current ratio of 2.82. The firm’s 50 day moving average price is $92.58 and its 200-day moving average price is $104.85. U.S. Physical Therapy, Inc. has a 52-week low of $78.17 and a 52-week high of $124.11. The company has a market cap of $1.24 billion, a PE ratio of 42.99, a P/E/G ratio of 4.12 and a beta of 1.37.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.02. U.S. Physical Therapy had a net margin of 5.25% and a return on equity of 9.22%. The firm had revenue of $151.50 million for the quarter, compared to the consensus estimate of $151.06 million. During the same period last year, the firm earned $0.90 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 8th. Shareholders of record on Friday, August 18th were paid a $0.43 dividend. The ex-dividend date was Thursday, August 17th. This represents a $1.72 annualized dividend and a yield of 2.07%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 89.12%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.